Autologous tumor tissue antigen-sensitized dendritic cell-cytokine-induced killer (DC-CIK) cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous tumor tissue antigen-sensitized dendritic cell-cytokine-induced killer (DC-CIK) cells, covering 2016-05-24 to 2016-05-24. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Tumor Tissue Antigen-sensitized DC-CIK Cells Combined With Chemotherapy for Esophageal Cancer [Phase 2]